On Monday, major U.S. indices closed positively, with the Dow Jones Industrial Average rising by 0.2% to 38,868.04. The S&P 500 increased by 0.3% to 5,360.79, and the Nasdaq climbed by 0.35% to finish at 17,192.53.

Apple Inc. (NASDAQ:AAPL)

Apple’s stock dipped by 1.91% to close at $193.12. The intraday high and low were $197.3 and $192.15, respectively, with a 52-week range of $164.08 to $199.62. Apple announced a partnership with Microsoft Corp.-backed OpenAI to integrate ChatGPT into its operating systems, a move that forms part of Apple's broader AI strategy.

Meta Platforms Inc. (NASDAQ:META)

Meta’s shares rose by 1.96% to close at $502.6. The stock hit an intraday high of $502.66 and a low of $493.41, with a 52-week range of $265.33 to $531.49. The company’s ongoing legal battle over the Cambridge Analytica scandal is heading to the U.S. Supreme Court, where justices said Monday that they will decide if a federal appeals court was wrong to let the lawsuit proceed on allegations that Meta inflated share prices by inadequately disclosing the risk of missed user data.

Celsius Holdings Inc. (NASDAQ:CELH)

See Also: Investor Naval Ravikant Threatens To Sell All Tesla Holdings If CEO Musk’s Pay Plan Is Rejected But Says

Celsius Holdings’ shares dropped by 9.60% to close at $66.17. The stock’s intraday high and low were $71 and $65.75, respectively, with a 52-week range of $45.03 to $99.62. The company’s shares moved on high trading volumes, with the company’s leadership set to participate in a webcast fireside chat at the 4th Annual Evercore ISI Consumer and Retail Conference.

Eli Lilly and Co (NYSE:LLY)

Eli Lilly’s stock rose by 1.77% to close at $865. The stock’s intraday high and low were $871.63 and $849.39, respectively, with a 52-week range of $434.34 to $871.63. The company shared detailed results from the SYNERGY-NASH phase 2 study. The study indicated that tirzepatide significantly improved metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis in patients, with up to 73.3% achieving MASH resolution without fibrosis worsening compared to 13.2% on placebo.

Tesla Inc. (NASDAQ:TSLA)

Tesla’s shares fell by 2.08% to close at $173.79. The stock’s intraday high and low were $178.57 and $173.17, respectively, with a 52-week range of $138.8 to $299.29. Tesla executives rallied in support of CEO Elon Musk’s $56 billion pay package.

Photo by Jirapong Manustrong on Shutterstock

Prepare for the day’s trading with top premarket movers and news by Benzinga.

Read Next: Trump Could Face Life Incarceration If Defeated In 2024 Election, Former Federal Prosecutor Warns: ‘He Has An Appreciable Chance Of Dying In Prison’

This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal